AAAAAA

   
Results: 1-10 |
Results: 10
COLLECTION AND USE OF PERIPHERAL-BLOOD STEM-CELLS IN YOUNG-CHILDREN WITH REFRACTORY SOLID TUMORS
Authors: SHEN V WOODBURY C KILLEN R VANDEVEN C SENDER L CAIRO MS
Citation: V. Shen et al., COLLECTION AND USE OF PERIPHERAL-BLOOD STEM-CELLS IN YOUNG-CHILDREN WITH REFRACTORY SOLID TUMORS, Bone marrow transplantation, 19(3), 1997, pp. 197-204
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - CHEMOPURGING, MODULATION OF MULTIPLE-DRUG RESISTANCE, INDUCTION OF AUTO GRAFT VS LEUKEMIA EFFECT, AND POST ABMT CHEMOIMMUNOTHERAPY
Authors: SENDER L ROSENTHAL J SETH T SWEETMAN R SECOLA R JACOBS C KILLEN R VANDEVEN C CAIRO MS
Citation: L. Sender et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - CHEMOPURGING, MODULATION OF MULTIPLE-DRUG RESISTANCE, INDUCTION OF AUTO GRAFT VS LEUKEMIA EFFECT, AND POST ABMT CHEMOIMMUNOTHERAPY, Experimental hematology, 24(9), 1996, pp. 635-635
PHASE-II TRIAL OF HEPARIN-PROPHYLAXIS FOR VENOOCCLUSIVE DISEASE OF THE LIVER IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION
Authors: ROSENTHAL J SENDER L SECOLA R KILLEN R MILLERICK M MURPHY L CAIRO MS
Citation: J. Rosenthal et al., PHASE-II TRIAL OF HEPARIN-PROPHYLAXIS FOR VENOOCCLUSIVE DISEASE OF THE LIVER IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 18(1), 1996, pp. 185-191
AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) WITH POSTTRANSPLANT IMMUNOTHERAPY AND CHEMOTHERAPY IN PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
Authors: ROSENTHAL J SLONE V VANDEVEN C KILLEN R SENDER L CAIRO MS
Citation: J. Rosenthal et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) WITH POSTTRANSPLANT IMMUNOTHERAPY AND CHEMOTHERAPY IN PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL), Blood, 88(10), 1996, pp. 491-491
PHYSIOLOGICAL-ROLE OF ENDOGENOUS IL-11 DURING THROMBOCYTOPENIA (TCP) FOLLOWING BONE-MARROW TRANSPLANT (BMT) AND DURING ACUTE IMMUNE THROMBOCYTOPENIA PURPURA (ITP)
Authors: SUEN Y BUSSEL J KILLEN R CAMERON K ELLIS R ROSENTHAL J CAIRO MS
Citation: Y. Suen et al., PHYSIOLOGICAL-ROLE OF ENDOGENOUS IL-11 DURING THROMBOCYTOPENIA (TCP) FOLLOWING BONE-MARROW TRANSPLANT (BMT) AND DURING ACUTE IMMUNE THROMBOCYTOPENIA PURPURA (ITP), Pediatric research, 37(4), 1995, pp. 166-166
COLLECTION AND ADMINISTRATION OF PBSC IN INFANTS AND YOUNG-CHILDREN -SAFE, FEASIBLE WITH ENHANCEMENT OF HEMATOLOGICAL RECONSTITUTION FOLLOWING MYELO AND SUB-MYELOABLATIVE TX
Authors: SHEN V BENNETTS G WOODBURY C CHANG L SENDER L KILLEN R CAIRO MS
Citation: V. Shen et al., COLLECTION AND ADMINISTRATION OF PBSC IN INFANTS AND YOUNG-CHILDREN -SAFE, FEASIBLE WITH ENHANCEMENT OF HEMATOLOGICAL RECONSTITUTION FOLLOWING MYELO AND SUB-MYELOABLATIVE TX, Blood, 86(10), 1995, pp. 1597-1597
AUTOLOGOUS BONE-MARROW TRANSPLANTATION (AMBT) FOLLOWED BY IMMUNOTHERAPY AND CHEMOTHERAPY FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
Authors: SETH T ROSENTHAL J SENDER LS CHANG L KILLEN R SWEETMAN R CAIRO MS
Citation: T. Seth et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (AMBT) FOLLOWED BY IMMUNOTHERAPY AND CHEMOTHERAPY FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL), Blood, 86(10), 1995, pp. 3847-3847
PHYSIOLOGICAL-ROLE OF ENDOGENOUS IL-11 DURING THROMBOCYTOPENIA POST MYELOABLATIVE THERAPY (MAT) AND BMT
Authors: SUEN Y CHANG M KILLEN R CAMERON K ROSENTHAL J CAIRO M
Citation: Y. Suen et al., PHYSIOLOGICAL-ROLE OF ENDOGENOUS IL-11 DURING THROMBOCYTOPENIA POST MYELOABLATIVE THERAPY (MAT) AND BMT, Blood, 84(10), 1994, pp. 10000091-10000091
MULTIPLE-DRUG RESISTANCE MODULATION AND INDUCTION OF GRAFT VS LEUKEMIA DURING AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) IN CHILDREN FOR ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
Authors: SWEETMAN R ROSENTHAL J WEINTHAL J SENDER L KILLEN R SECOLA R VANDEVEN C CAIRO MS
Citation: R. Sweetman et al., MULTIPLE-DRUG RESISTANCE MODULATION AND INDUCTION OF GRAFT VS LEUKEMIA DURING AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) IN CHILDREN FOR ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL), Blood, 84(10), 1994, pp. 10000722-10000722
SAFETY AND EFFICACY OF HEPARIN-PROPHYLAXIS AND TISSUE-PLASMINOGEN ACTIVATOR (TPA) TREATMENT FOR VENOOCCLUSIVE DISEASE (VOD) OF THE LIVER INCHILDREN FOLLOWING BONE-MARROW TRANSPLANTATION (BMT)
Authors: ROSENTHAL J SENDER L MONTES V WEINTHAL J SUAREZ M LORANGER N SECOLA R KILLEN R GOWAN D FLORENCE K MEIMAN S CAIRO MS
Citation: J. Rosenthal et al., SAFETY AND EFFICACY OF HEPARIN-PROPHYLAXIS AND TISSUE-PLASMINOGEN ACTIVATOR (TPA) TREATMENT FOR VENOOCCLUSIVE DISEASE (VOD) OF THE LIVER INCHILDREN FOLLOWING BONE-MARROW TRANSPLANTATION (BMT), Blood, 82(10), 1993, pp. 10000410-10000410
Risultati: 1-10 |